Search results
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 14 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
BioNTech gets $145 million funding for African vaccine plants
Reuters via Yahoo News· 6 days agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 4 days agovaccine trial. The company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 18 hours agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 4 days agoSo he signed up to a trial of an investigational vaccine made by German pharma company BioNTech,...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 23 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna's RSV Vaccine Approved by FDA
Medscape· 23 hours agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations ...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 3 days agoThose two products represented just $2.4 billion of Pfizer's $14.9 billion in first-quarter 2024 sales. That revenue should tail off more...accumulating...